Sign in
4

Changes in Ownership

Dogwood Therapeutics, Inc. Filed Acc 0001415889-23-012375

CHIEF EXECUTIVE OFFICER bought 25,000 shares at $1.25 ($31,245)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER 2023-08-17 Purchase +25,000 $1.25 $31,245 57,461 D
Open-market purchases · 25,000 sh · avg $1.25 · $31,245
Loading xslF345X05/form4-08182023_070801.xml…